nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS2—melanoma	0.597	1	CbGaD
L-Arginine—SLC22A5—Dactinomycin—melanoma	0.0594	1	CbGbCtD
L-Arginine—Edema cerebral—Carmustine—melanoma	0.00936	0.112	CcSEcCtD
L-Arginine—Edema cerebral—Temozolomide—melanoma	0.00905	0.108	CcSEcCtD
L-Arginine—NOS3—umbilical vein—melanoma	0.00799	0.104	CbGeAlD
L-Arginine—NOS3—hindlimb—melanoma	0.00732	0.0949	CbGeAlD
L-Arginine—NOS3—appendage—melanoma	0.00628	0.0814	CbGeAlD
L-Arginine—Brain oedema—Carmustine—melanoma	0.00507	0.0607	CcSEcCtD
L-Arginine—Brain oedema—Temozolomide—melanoma	0.0049	0.0586	CcSEcCtD
L-Arginine—Skin necrosis—Carmustine—melanoma	0.00414	0.0496	CcSEcCtD
L-Arginine—NOS3—endothelium—melanoma	0.00379	0.0492	CbGeAlD
L-Arginine—ASS1—hair follicle—melanoma	0.00374	0.0485	CbGeAlD
L-Arginine—ARG2—neck—melanoma	0.00358	0.0464	CbGeAlD
L-Arginine—NOS3—blood vessel—melanoma	0.00349	0.0453	CbGeAlD
L-Arginine—SLC7A4—head—melanoma	0.00302	0.0392	CbGeAlD
L-Arginine—L-Cysteine—MGMT—melanoma	0.00271	0.752	CrCbGaD
L-Arginine—ASL—head—melanoma	0.00269	0.035	CbGeAlD
L-Arginine—ARG2—eye—melanoma	0.00266	0.0345	CbGeAlD
L-Arginine—ARG2—retina—melanoma	0.00264	0.0342	CbGeAlD
L-Arginine—NOS3—neck—melanoma	0.0025	0.0324	CbGeAlD
L-Arginine—ARG2—mammalian vulva—melanoma	0.00211	0.0274	CbGeAlD
L-Arginine—AZIN2—lymph node—melanoma	0.00203	0.0263	CbGeAlD
L-Arginine—Necrosis—Dactinomycin—melanoma	0.00197	0.0236	CcSEcCtD
L-Arginine—Extravasation—Bleomycin—melanoma	0.0019	0.0228	CcSEcCtD
L-Arginine—ASL—lymph node—melanoma	0.00189	0.0245	CbGeAlD
L-Arginine—ASS1—eye—melanoma	0.00187	0.0242	CbGeAlD
L-Arginine—Necrosis—Carmustine—melanoma	0.00185	0.0221	CcSEcCtD
L-Arginine—SLC16A10—neck—melanoma	0.00179	0.0232	CbGeAlD
L-Arginine—Extravasation—Dactinomycin—melanoma	0.00177	0.0212	CcSEcCtD
L-Arginine—SLC7A1—head—melanoma	0.00177	0.0229	CbGeAlD
L-Arginine—Extravasation—Carmustine—melanoma	0.00166	0.0199	CcSEcCtD
L-Arginine—ASS1—skin of body—melanoma	0.00162	0.0211	CbGeAlD
L-Arginine—SLC22A4—neck—melanoma	0.0016	0.0207	CbGeAlD
L-Arginine—Skin exfoliation—Bleomycin—melanoma	0.00158	0.019	CcSEcCtD
L-Arginine—ARG2—head—melanoma	0.00151	0.0196	CbGeAlD
L-Arginine—ASS1—mammalian vulva—melanoma	0.00148	0.0192	CbGeAlD
L-Arginine—Injection site reaction—Carmustine—melanoma	0.00144	0.0172	CcSEcCtD
L-Arginine—Skin exfoliation—Carmustine—melanoma	0.00138	0.0166	CcSEcCtD
L-Arginine—Skin exfoliation—Temozolomide—melanoma	0.00134	0.016	CcSEcCtD
L-Arginine—SLC7A1—lymph node—melanoma	0.00124	0.016	CbGeAlD
L-Arginine—Swelling—Carmustine—melanoma	0.00119	0.0143	CcSEcCtD
L-Arginine—Necrosis—Docetaxel—melanoma	0.00119	0.0142	CcSEcCtD
L-Arginine—Lethargy—Dactinomycin—melanoma	0.00115	0.0137	CcSEcCtD
L-Arginine—Extravasation—Docetaxel—melanoma	0.00107	0.0128	CcSEcCtD
L-Arginine—ASS1—head—melanoma	0.00106	0.0137	CbGeAlD
L-Arginine—ARG2—lymph node—melanoma	0.00106	0.0137	CbGeAlD
L-Arginine—SLC16A10—mammalian vulva—melanoma	0.00106	0.0137	CbGeAlD
L-Arginine—NOS3—head—melanoma	0.00106	0.0137	CbGeAlD
L-Arginine—Anaphylactic shock—Vemurafenib—melanoma	0.000977	0.0117	CcSEcCtD
L-Arginine—Injection site reaction—Docetaxel—melanoma	0.000925	0.0111	CcSEcCtD
L-Arginine—L-Citrulline—NOS2—melanoma	0.000894	0.248	CrCbGaD
L-Arginine—Skin exfoliation—Docetaxel—melanoma	0.000889	0.0106	CcSEcCtD
L-Arginine—Haematuria—Bleomycin—melanoma	0.000885	0.0106	CcSEcCtD
L-Arginine—Decreased appetite—Vemurafenib—melanoma	0.000849	0.0102	CcSEcCtD
L-Arginine—Hypoaesthesia—Bleomycin—melanoma	0.000829	0.00992	CcSEcCtD
L-Arginine—SLC22A5—retina—melanoma	0.000778	0.0101	CbGeAlD
L-Arginine—Flushing—Bleomycin—melanoma	0.000773	0.00926	CcSEcCtD
L-Arginine—Swelling—Docetaxel—melanoma	0.000766	0.00917	CcSEcCtD
L-Arginine—ASS1—lymph node—melanoma	0.000741	0.00962	CbGeAlD
L-Arginine—NOS3—lymph node—melanoma	0.000739	0.00959	CbGeAlD
L-Arginine—Hypoaesthesia—Carmustine—melanoma	0.000724	0.00866	CcSEcCtD
L-Arginine—Flushing—Dactinomycin—melanoma	0.000721	0.00863	CcSEcCtD
L-Arginine—Hypersensitivity—Vemurafenib—melanoma	0.00072	0.00862	CcSEcCtD
L-Arginine—Hypoaesthesia—Temozolomide—melanoma	0.000699	0.00837	CcSEcCtD
L-Arginine—Lethargy—Docetaxel—melanoma	0.000689	0.00825	CcSEcCtD
L-Arginine—SLC22A5—skin of body—melanoma	0.000683	0.00886	CbGeAlD
L-Arginine—Flushing—Carmustine—melanoma	0.000675	0.00808	CcSEcCtD
L-Arginine—Flushing—Temozolomide—melanoma	0.000652	0.00781	CcSEcCtD
L-Arginine—Vomiting—Vemurafenib—melanoma	0.000621	0.00744	CcSEcCtD
L-Arginine—Rash—Vemurafenib—melanoma	0.000616	0.00737	CcSEcCtD
L-Arginine—Dermatitis—Vemurafenib—melanoma	0.000615	0.00737	CcSEcCtD
L-Arginine—Headache—Vemurafenib—melanoma	0.000612	0.00733	CcSEcCtD
L-Arginine—Anaphylactic shock—Bleomycin—melanoma	0.000592	0.00709	CcSEcCtD
L-Arginine—Nausea—Vemurafenib—melanoma	0.00058	0.00695	CcSEcCtD
L-Arginine—Anorexia—Bleomycin—melanoma	0.000564	0.00675	CcSEcCtD
L-Arginine—SLC16A10—lymph node—melanoma	0.00053	0.00687	CbGeAlD
L-Arginine—Anorexia—Dactinomycin—melanoma	0.000526	0.0063	CcSEcCtD
L-Arginine—Decreased appetite—Bleomycin—melanoma	0.000515	0.00616	CcSEcCtD
L-Arginine—Tachycardia—Carmustine—melanoma	0.000504	0.00604	CcSEcCtD
L-Arginine—Anaphylactic shock—Temozolomide—melanoma	0.000499	0.00598	CcSEcCtD
L-Arginine—Anorexia—Carmustine—melanoma	0.000493	0.0059	CcSEcCtD
L-Arginine—Hyperhidrosis—Temozolomide—melanoma	0.000483	0.00578	CcSEcCtD
L-Arginine—Decreased appetite—Dactinomycin—melanoma	0.00048	0.00574	CcSEcCtD
L-Arginine—Anorexia—Temozolomide—melanoma	0.000476	0.0057	CcSEcCtD
L-Arginine—SLC22A4—lymph node—melanoma	0.000472	0.00612	CbGeAlD
L-Arginine—Hypoaesthesia—Docetaxel—melanoma	0.000465	0.00557	CcSEcCtD
L-Arginine—Decreased appetite—Carmustine—melanoma	0.000449	0.00538	CcSEcCtD
L-Arginine—Hypersensitivity—Bleomycin—melanoma	0.000436	0.00522	CcSEcCtD
L-Arginine—Decreased appetite—Temozolomide—melanoma	0.000434	0.0052	CcSEcCtD
L-Arginine—Flushing—Docetaxel—melanoma	0.000434	0.00519	CcSEcCtD
L-Arginine—Hypersensitivity—Dactinomycin—melanoma	0.000407	0.00487	CcSEcCtD
L-Arginine—Hypersensitivity—Carmustine—melanoma	0.000381	0.00456	CcSEcCtD
L-Arginine—Vomiting—Bleomycin—melanoma	0.000376	0.00451	CcSEcCtD
L-Arginine—Rash—Bleomycin—melanoma	0.000373	0.00447	CcSEcCtD
L-Arginine—Dermatitis—Bleomycin—melanoma	0.000373	0.00446	CcSEcCtD
L-Arginine—Hypersensitivity—Temozolomide—melanoma	0.000368	0.0044	CcSEcCtD
L-Arginine—Nausea—Bleomycin—melanoma	0.000352	0.00421	CcSEcCtD
L-Arginine—Vomiting—Dactinomycin—melanoma	0.000351	0.0042	CcSEcCtD
L-Arginine—Rash—Dactinomycin—melanoma	0.000348	0.00417	CcSEcCtD
L-Arginine—Anaphylactic shock—Docetaxel—melanoma	0.000332	0.00397	CcSEcCtD
L-Arginine—Vomiting—Carmustine—melanoma	0.000329	0.00393	CcSEcCtD
L-Arginine—Nausea—Dactinomycin—melanoma	0.000328	0.00393	CcSEcCtD
L-Arginine—Rash—Carmustine—melanoma	0.000326	0.0039	CcSEcCtD
L-Arginine—Dermatitis—Carmustine—melanoma	0.000326	0.0039	CcSEcCtD
L-Arginine—Tachycardia—Docetaxel—melanoma	0.000324	0.00388	CcSEcCtD
L-Arginine—Headache—Carmustine—melanoma	0.000324	0.00387	CcSEcCtD
L-Arginine—Vomiting—Temozolomide—melanoma	0.000317	0.0038	CcSEcCtD
L-Arginine—Anorexia—Docetaxel—melanoma	0.000317	0.00379	CcSEcCtD
L-Arginine—Rash—Temozolomide—melanoma	0.000315	0.00377	CcSEcCtD
L-Arginine—Dermatitis—Temozolomide—melanoma	0.000315	0.00377	CcSEcCtD
L-Arginine—Headache—Temozolomide—melanoma	0.000313	0.00374	CcSEcCtD
L-Arginine—SLC22A5—lymph node—melanoma	0.000312	0.00405	CbGeAlD
L-Arginine—Nausea—Carmustine—melanoma	0.000307	0.00367	CcSEcCtD
L-Arginine—Nausea—Temozolomide—melanoma	0.000297	0.00355	CcSEcCtD
L-Arginine—Decreased appetite—Docetaxel—melanoma	0.000289	0.00346	CcSEcCtD
L-Arginine—Hypersensitivity—Docetaxel—melanoma	0.000245	0.00293	CcSEcCtD
L-Arginine—Vomiting—Docetaxel—melanoma	0.000211	0.00253	CcSEcCtD
L-Arginine—Rash—Docetaxel—melanoma	0.000209	0.00251	CcSEcCtD
L-Arginine—Dermatitis—Docetaxel—melanoma	0.000209	0.0025	CcSEcCtD
L-Arginine—Headache—Docetaxel—melanoma	0.000208	0.00249	CcSEcCtD
L-Arginine—Nausea—Docetaxel—melanoma	0.000197	0.00236	CcSEcCtD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—HRAS—melanoma	3.56e-05	0.000198	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTEN—melanoma	3.56e-05	0.000198	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PLA2G6—melanoma	3.55e-05	0.000197	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—melanoma	3.53e-05	0.000197	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCR1—melanoma	3.49e-05	0.000194	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SKI—melanoma	3.49e-05	0.000194	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—FN1—melanoma	3.46e-05	0.000193	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MC1R—melanoma	3.44e-05	0.000191	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NOS2—melanoma	3.42e-05	0.00019	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CB—melanoma	3.41e-05	0.00019	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTGS2—melanoma	3.38e-05	0.000188	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ABCB1—melanoma	3.36e-05	0.000187	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT3—melanoma	3.35e-05	0.000186	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CG—melanoma	3.31e-05	0.000184	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GRM1—melanoma	3.3e-05	0.000183	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR7—melanoma	3.3e-05	0.000183	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—EGF—melanoma	3.28e-05	0.000182	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CB—melanoma	3.27e-05	0.000182	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SUFU—melanoma	3.21e-05	0.000179	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—VCAN—melanoma	3.19e-05	0.000177	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—AKT1—melanoma	3.15e-05	0.000175	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CG—melanoma	3.09e-05	0.000172	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IGF1—melanoma	3.03e-05	0.000169	CbGpPWpGaD
L-Arginine—NOS3—Disease—GAB2—melanoma	3.03e-05	0.000169	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IL2—melanoma	3e-05	0.000167	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BCL2L11—melanoma	3e-05	0.000167	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RHOB—melanoma	3e-05	0.000167	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PPARG—melanoma	2.98e-05	0.000166	CbGpPWpGaD
L-Arginine—NOS3—Disease—FASN—melanoma	2.97e-05	0.000165	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERBB4—melanoma	2.96e-05	0.000165	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTEN—melanoma	2.95e-05	0.000164	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN2B—melanoma	2.93e-05	0.000163	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CD—melanoma	2.91e-05	0.000162	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HDAC6—melanoma	2.88e-05	0.00016	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—ALB—melanoma	2.88e-05	0.00016	CbGpPWpGaD
L-Arginine—NOS3—Disease—CXCR4—melanoma	2.85e-05	0.000159	CbGpPWpGaD
L-Arginine—NOS3—Disease—FOXO4—melanoma	2.85e-05	0.000159	CbGpPWpGaD
L-Arginine—NOS3—Disease—HDAC2—melanoma	2.85e-05	0.000159	CbGpPWpGaD
L-Arginine—NOS2—Disease—CD86—melanoma	2.84e-05	0.000158	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD44—melanoma	2.82e-05	0.000157	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—ALB—melanoma	2.79e-05	0.000155	CbGpPWpGaD
L-Arginine—NOS2—Disease—FGF1—melanoma	2.75e-05	0.000153	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—ALB—melanoma	2.75e-05	0.000153	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CA—melanoma	2.75e-05	0.000153	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCR2—melanoma	2.73e-05	0.000152	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CD—melanoma	2.71e-05	0.000151	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP17A1—melanoma	2.69e-05	0.00015	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RAC2—melanoma	2.69e-05	0.000149	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ALB—melanoma	2.68e-05	0.000149	CbGpPWpGaD
L-Arginine—NOS2—Disease—PDGFRA—melanoma	2.67e-05	0.000148	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFC—melanoma	2.65e-05	0.000147	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—WNT5A—melanoma	2.65e-05	0.000147	CbGpPWpGaD
L-Arginine—NOS2—Disease—PRKCA—melanoma	2.64e-05	0.000147	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERCC2—melanoma	2.62e-05	0.000146	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT3—melanoma	2.6e-05	0.000145	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAP2K2—melanoma	2.58e-05	0.000143	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—melanoma	2.55e-05	0.000142	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GNA11—melanoma	2.54e-05	0.000141	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CB—melanoma	2.54e-05	0.000141	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—NRAS—melanoma	2.52e-05	0.00014	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CA—melanoma	2.51e-05	0.00014	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—FASN—melanoma	2.49e-05	0.000138	CbGpPWpGaD
L-Arginine—NOS2—Disease—HLA-A—melanoma	2.45e-05	0.000136	CbGpPWpGaD
L-Arginine—NOS2—Disease—TERT—melanoma	2.45e-05	0.000136	CbGpPWpGaD
L-Arginine—NOS2—Disease—RAC1—melanoma	2.45e-05	0.000136	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC5A5—melanoma	2.45e-05	0.000136	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—MAPK3—melanoma	2.42e-05	0.000134	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CB—melanoma	2.37e-05	0.000132	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CD44—melanoma	2.36e-05	0.000131	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GNAQ—melanoma	2.36e-05	0.000131	CbGpPWpGaD
L-Arginine—NOS2—Disease—HIF1A—melanoma	2.35e-05	0.000131	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—melanoma	2.34e-05	0.00013	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IL2—melanoma	2.33e-05	0.00013	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—F2R—melanoma	2.32e-05	0.000129	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB4—melanoma	2.3e-05	0.000128	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—MAPK1—melanoma	2.3e-05	0.000128	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN2B—melanoma	2.28e-05	0.000127	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP1B1—melanoma	2.26e-05	0.000126	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EDNRB—melanoma	2.25e-05	0.000125	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—melanoma	2.24e-05	0.000125	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD86—melanoma	2.2e-05	0.000123	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTK2B—melanoma	2.18e-05	0.000121	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KRAS—melanoma	2.17e-05	0.000121	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGF1—melanoma	2.14e-05	0.000119	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GAB2—melanoma	2.12e-05	0.000118	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GNA11—melanoma	2.12e-05	0.000118	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FLT1—melanoma	2.11e-05	0.000118	CbGpPWpGaD
L-Arginine—NOS2—Disease—NOTCH1—melanoma	2.11e-05	0.000118	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ALB—melanoma	2.1e-05	0.000117	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CA—melanoma	2.08e-05	0.000116	CbGpPWpGaD
L-Arginine—NOS2—Disease—CD80—melanoma	2.07e-05	0.000115	CbGpPWpGaD
L-Arginine—NOS3—Disease—PDGFRA—melanoma	2.07e-05	0.000115	CbGpPWpGaD
L-Arginine—NOS2—Disease—APC—melanoma	2.07e-05	0.000115	CbGpPWpGaD
L-Arginine—NOS2—Disease—KIT—melanoma	2.07e-05	0.000115	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—melanoma	2.05e-05	0.000114	CbGpPWpGaD
L-Arginine—NOS3—Disease—PRKCA—melanoma	2.05e-05	0.000114	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTEN—melanoma	2.04e-05	0.000114	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGF—melanoma	2.04e-05	0.000114	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERCC2—melanoma	2.03e-05	0.000113	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAP2K2—melanoma	2e-05	0.000111	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FOXO4—melanoma	2e-05	0.000111	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HDAC2—melanoma	2e-05	0.000111	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCR4—melanoma	2e-05	0.000111	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CA—melanoma	1.99e-05	0.000111	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—melanoma	1.98e-05	0.00011	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GNAQ—melanoma	1.97e-05	0.00011	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NRAS—melanoma	1.96e-05	0.000109	CbGpPWpGaD
L-Arginine—NOS2—Disease—BRAF—melanoma	1.94e-05	0.000108	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—melanoma	1.93e-05	0.000107	CbGpPWpGaD
L-Arginine—NOS3—Disease—TERT—melanoma	1.9e-05	0.000106	CbGpPWpGaD
L-Arginine—NOS3—Disease—HLA-A—melanoma	1.9e-05	0.000106	CbGpPWpGaD
L-Arginine—NOS3—Disease—RAC1—melanoma	1.9e-05	0.000106	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—MAPK3—melanoma	1.88e-05	0.000104	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ABCB1—melanoma	1.86e-05	0.000104	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SYK—melanoma	1.86e-05	0.000103	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—melanoma	1.84e-05	0.000103	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAP2K1—melanoma	1.83e-05	0.000102	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT3—melanoma	1.82e-05	0.000101	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ITGAV—melanoma	1.82e-05	0.000101	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NGFR—melanoma	1.82e-05	0.000101	CbGpPWpGaD
L-Arginine—NOS3—Disease—HIF1A—melanoma	1.82e-05	0.000101	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CD—melanoma	1.82e-05	0.000101	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—MAPK1—melanoma	1.78e-05	9.93e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—FGF2—melanoma	1.74e-05	9.68e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PRKCA—melanoma	1.72e-05	9.54e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ERCC2—melanoma	1.7e-05	9.47e-05	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—melanoma	1.7e-05	9.46e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SOCS1—melanoma	1.69e-05	9.39e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KRAS—melanoma	1.69e-05	9.38e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—S100B—melanoma	1.68e-05	9.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—NOS2—melanoma	1.66e-05	9.22e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—NOTCH1—melanoma	1.64e-05	9.13e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—melanoma	1.63e-05	9.06e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MDM2—melanoma	1.63e-05	9.05e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB4—melanoma	1.61e-05	8.95e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD80—melanoma	1.61e-05	8.94e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERBB2—melanoma	1.6e-05	8.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—KIT—melanoma	1.6e-05	8.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—APC—melanoma	1.6e-05	8.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN2B—melanoma	1.6e-05	8.88e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGF—melanoma	1.59e-05	8.82e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CB—melanoma	1.58e-05	8.81e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CD4—melanoma	1.58e-05	8.79e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—melanoma	1.57e-05	8.73e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CA—melanoma	1.55e-05	8.61e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CD86—melanoma	1.54e-05	8.58e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EDN1—melanoma	1.53e-05	8.52e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—BRAF—melanoma	1.51e-05	8.39e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—melanoma	1.5e-05	8.33e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CSF2—melanoma	1.5e-05	8.32e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGF1—melanoma	1.5e-05	8.32e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1B—melanoma	1.49e-05	8.27e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—E2F1—melanoma	1.46e-05	8.15e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PDGFRA—melanoma	1.45e-05	8.06e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CA—melanoma	1.44e-05	8.02e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ITGB3—melanoma	1.43e-05	7.98e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PRKCA—melanoma	1.43e-05	7.98e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—melanoma	1.43e-05	7.97e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAP2K1—melanoma	1.42e-05	7.9e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CD—melanoma	1.41e-05	7.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SPP1—melanoma	1.41e-05	7.83e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CTNNB1—melanoma	1.4e-05	7.81e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAP2K2—melanoma	1.4e-05	7.8e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1A—melanoma	1.37e-05	7.63e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTEN—melanoma	1.37e-05	7.61e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGF2—melanoma	1.35e-05	7.51e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CG—melanoma	1.34e-05	7.48e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TERT—melanoma	1.33e-05	7.42e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RAC1—melanoma	1.33e-05	7.4e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PPARG—melanoma	1.3e-05	7.22e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HIF1A—melanoma	1.28e-05	7.1e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—melanoma	1.26e-05	7.04e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MDM2—melanoma	1.26e-05	7.03e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB2—melanoma	1.25e-05	6.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CB—melanoma	1.23e-05	6.84e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD4—melanoma	1.23e-05	6.83e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—STAT3—melanoma	1.22e-05	6.81e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—NRAS—melanoma	1.22e-05	6.79e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KDR—melanoma	1.22e-05	6.79e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—melanoma	1.22e-05	6.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CD—melanoma	1.18e-05	6.57e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—melanoma	1.18e-05	6.55e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FN1—melanoma	1.17e-05	6.53e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAPK3—melanoma	1.17e-05	6.5e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ALB—melanoma	1.17e-05	6.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1B—melanoma	1.15e-05	6.42e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NOTCH1—melanoma	1.15e-05	6.39e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MYC—melanoma	1.14e-05	6.33e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CD80—melanoma	1.13e-05	6.26e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APC—melanoma	1.12e-05	6.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CG—melanoma	1.12e-05	6.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KIT—melanoma	1.12e-05	6.25e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAPK1—melanoma	1.11e-05	6.19e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGFR—melanoma	1.11e-05	6.19e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGF—melanoma	1.11e-05	6.18e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CTNNB1—melanoma	1.09e-05	6.06e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1A—melanoma	1.06e-05	5.92e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTEN—melanoma	1.06e-05	5.91e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BRAF—melanoma	1.06e-05	5.88e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—KRAS—melanoma	1.05e-05	5.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CB—melanoma	1.03e-05	5.73e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IGF1—melanoma	1.03e-05	5.72e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—melanoma	1.02e-05	5.68e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAP2K1—melanoma	9.94e-06	5.53e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CD—melanoma	9.88e-06	5.5e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CA—melanoma	9.65e-06	5.37e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—STAT3—melanoma	9.5e-06	5.29e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—NRAS—melanoma	9.48e-06	5.27e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGF2—melanoma	9.46e-06	5.26e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAPK3—melanoma	9.08e-06	5.05e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—melanoma	8.93e-06	4.97e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTEN—melanoma	8.9e-06	4.95e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MDM2—melanoma	8.85e-06	4.92e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MYC—melanoma	8.83e-06	4.91e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB2—melanoma	8.73e-06	4.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAPK1—melanoma	8.64e-06	4.81e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGFR—melanoma	8.64e-06	4.8e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CB—melanoma	8.61e-06	4.79e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—IL6—melanoma	8.55e-06	4.76e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL8—melanoma	8.27e-06	4.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—KRAS—melanoma	8.16e-06	4.54e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1B—melanoma	8.08e-06	4.5e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP3—melanoma	7.92e-06	4.41e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL2—melanoma	7.91e-06	4.4e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—melanoma	7.89e-06	4.39e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCND1—melanoma	7.71e-06	4.29e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CTNNB1—melanoma	7.63e-06	4.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CA—melanoma	7.5e-06	4.17e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP9—melanoma	7.48e-06	4.16e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1A—melanoma	7.46e-06	4.15e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTEN—melanoma	7.44e-06	4.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NFKB1—melanoma	7.4e-06	4.12e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—melanoma	6.94e-06	3.86e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—melanoma	6.72e-06	3.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT3—melanoma	6.65e-06	3.7e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRAS—melanoma	6.64e-06	3.69e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—IL6—melanoma	6.64e-06	3.69e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAPK3—melanoma	6.36e-06	3.54e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CA—melanoma	6.28e-06	3.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MYC—melanoma	6.18e-06	3.44e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—melanoma	6.12e-06	3.41e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAPK1—melanoma	6.05e-06	3.37e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGFR—melanoma	6.05e-06	3.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KRAS—melanoma	5.71e-06	3.18e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CA—melanoma	5.25e-06	2.92e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—melanoma	5.13e-06	2.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—melanoma	5.08e-06	2.82e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—melanoma	4.86e-06	2.7e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL6—melanoma	4.65e-06	2.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—melanoma	4.29e-06	2.39e-05	CbGpPWpGaD
